Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Rapid Therapeutic Science Laboratories, Inc. (RTSL) Debt Ratio (2016 - 2023)

Rapid Therapeutic Science Laboratories' Debt Ratio history spans 8 years, with the latest figure at 0.03 for Q2 2023.

  • For Q2 2023, Debt Ratio fell 94.09% year-over-year to 0.03; the TTM value through Jun 2023 reached 0.03, down 94.09%, while the annual FY2022 figure was 0.02, N/A changed from the prior year.
  • Debt Ratio for Q2 2023 was 0.03 at Rapid Therapeutic Science Laboratories, down from 0.06 in the prior quarter.
  • Across five years, Debt Ratio topped out at 303.74 in Q2 2019 and bottomed at 0.02 in Q4 2022.
  • The 5-year median for Debt Ratio is 0.25 (2020), against an average of 44.93.
  • The largest annual shift saw Debt Ratio plummeted 98.29% in 2020 before it plummeted 85.01% in 2023.
  • A 5-year view of Debt Ratio shows it stood at 1.67 in 2019, then tumbled by 98.29% to 0.03 in 2020, then surged by 1874.57% to 0.57 in 2021, then tumbled by 96.81% to 0.02 in 2022, then skyrocketed by 43.24% to 0.03 in 2023.
  • Per Business Quant, the three most recent readings for RTSL's Debt Ratio are 0.03 (Q2 2023), 0.06 (Q1 2023), and 0.02 (Q4 2022).